IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors

NCT05991518 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2 Gene Mutation

Interventions

COMBINATION_PRODUCT: Injection of IAH0968+Gemcitabine+Cisplatin
COMBINATION_PRODUCT: Gemcitabine+Cisplatin

Sponsor

SUNHO（China）BioPharmaceutical CO., Ltd.